In thyroid cancer, studies have reported that FTO regulates ferroptosis responsiveness by inhibiting m6A modification of SLC7A11 mRNA, while ALKBH5 regulates ferroptosis in thyroid cancer through the classical antioxidant stress pathway Nrf2/HO‐1.[35] However, documentation regarding the regulation of ferroptosis by these two key m6A erasers in other tumors remains limited. Here, ALKBH5 is linked to thyroid gland carcinoma.